Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition

NCT ID: NCT04323059

Last Updated: 2020-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-30

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized clinical trial aimed at evaluating the effectiveness, tolerability and safety of standardized milk-based formulation, standardized non-milk based formulation and a hospital-based formulation in the management of children aged 6 - 59 months with moderate acute malnutrition. Eligible children will be randomized into one of the three intervention arms and given supplementary doses of the formulations at 50% of their daily caloric requirement for a period of four months based on the group of their assignment. The remainder will be obtained from their regular family diets. The clinical features, anthropometric measurements and laboratory parameters of the children will be assessed at baseline. The children will be followed up on two weekly basis for a period of four months during which further clinical assessment, anthropometric measurements and laboratory evaluations will be performed. The outcome measures will be determined based on "per protocol analysis".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Childhood malnutrition is presently a leading cause of underfive morbidity and mortality globally. The impact of the condition is most severe in the first 1000 days of life with resultant impairment in physical, neurologic, immunologic and metabolic development.

Undernutrition, the commoner form of childhood malnutrition, is usually classified as underweight (weight-for-age Z score \< -2), stunting (height-for-age Z score \<-2), wasting (weight-for-height Z score \< -2) or edematous malnutrition (kwashiorkor) in relation to the World Health Organization standard reference values for age and sex. It is further sub-classified into severe acute malnutrition (SAM) wherein z score is \<-3 and moderate acute malnutrition (MAM) wherein z score is between -2 and -3.(1) MAM accounts for about 70.0% of all malnutrition-related childhood deaths.

Children with MAM are currently managed using community-based approach. This approach entails early detection and treatment of children with MAM in the community, timely referral to inpatient care for those that progress to SAM or develop complications, and subsequent follow up in the community at discharge. MAM is usually managed by nutrition education of the caregivers on preparation of nutritious, palatable and culturally acceptable food from locally available food stuffs like banana porridge or corn gruel fortified with legume (mashed groundnut or soya bean), crayfish, palm oil, powdered milk and vegetables. The second strategy is by Ready-to-use therapeutic foods (RUTFs). (2) The main drawback of the RUTFs is that they are usually provided by external donor agencies and as such, not always available in settings where childhood malnutrition is endemic. Children treated with RUTFs are therefore at risk of progressing to SAM or dying when the formulations are no longer available. There is currently no consensus on the appropriate nutritional formulation for community-based management of MAM in children in endemic regions. It is therefore imperative to evaluate the effect of readily available formulations that are comparable to the RUTFs in community-based management of childhood MAM in endemic regions. (3) The standardized milk-based formulation (SMBF), the standardized non milk-based formulation (SNMBF) and the hospital-based formulation (HBF) are examples of formulations that are readily available in the country. The SMBF consists of maize and is rich in methionine, the SNMBF consists of maize and soybeans, and is rich in methionine and lysine while the HBF consist of a combination of maize, milk and soybeans. The nutrient composition of the above-mentioned formulations is similar to that of the RUTFs, making them suitable for community-based management of MAM. However, no clinical trial has so far been conducted to evaluate their effect in managing underfive children with MAM. The cost effectiveness of the various formulations will also be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malnutrition; Moderate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study participants will be randomized into three different intervention groups. Based on the group of assignment, the participants will receive either the standardized milk-based formulation, the standardized non-milk based formulation or the hospital-based formulation.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standardized milk-based formulation

Formulation of maize with milk that is rich in methionine

Group Type EXPERIMENTAL

Standardized milk-based formulation

Intervention Type DIETARY_SUPPLEMENT

Nutritional formulations prepared from locally available food stuffs for reversing childhood malnutrition

Standardized non-milk based formulation

Formulation of maize with soybeans that is rich in methionine and lysine

Group Type EXPERIMENTAL

Standardized milk-based formulation

Intervention Type DIETARY_SUPPLEMENT

Nutritional formulations prepared from locally available food stuffs for reversing childhood malnutrition

Hospital-based formulation

Formulation of maize, milk and soybeans

Group Type ACTIVE_COMPARATOR

Standardized milk-based formulation

Intervention Type DIETARY_SUPPLEMENT

Nutritional formulations prepared from locally available food stuffs for reversing childhood malnutrition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standardized milk-based formulation

Nutritional formulations prepared from locally available food stuffs for reversing childhood malnutrition

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Standardized non-milk based formulation Hospital-based formulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Children aged 6 - 59 months with moderate acute malnutrition (weight-for-height between -2 and -3 Z scores or mid upper arm circumference of 11.5 cm - 12.5 cm).
2. Children whose parents/guardian consent to their participation and agree to bring the children/wards to the health facility throughout the period of the study.

Exclusion Criteria

1. Children with chronic illnesses that may affect growth {(cardiac disease, renal disease, tuberculosis (chronic cough, history of contact with an adult with chronic cough, poor growth, chest infection not responding to antibiotics) liver disease, HIV/AIDS}
2. Children with feeding difficulties eg. Gastroesophageal reflux diseases, cleft palate
3. Children with diarrhoea
4. Children with neurological diseases eg. Cerebral palsy
5. Children less than 6 months or more 59 months of age
Minimum Eligible Age

6 Months

Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. Ekong E. Udoh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Ekong E. Udoh

DOCTOR

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ekong E Udoh, FWACPaed

Role: PRINCIPAL_INVESTIGATOR

University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria

Sunday B Adesina, FWACPaed

Role: STUDY_DIRECTOR

University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria

Blessing N Nwazuluoke, BSc

Role: STUDY_CHAIR

University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Primary Health Centre, Okpoediuse

Ibiono Ibom, Akwa Ibom State, Nigeria

Site Status

Primary Health Centre, Adadiah

Uruan, Akwa Ibom State, Nigeria

Site Status

Primary Health centre, Mbak-Etoi

Uyo, Akwa Ibom State, Nigeria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nigeria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ekong E Udoh, FWACPaed

Role: CONTACT

+234(0)38355559

Sunday B Adesina

Role: CONTACT

+234(0)8035036479

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Edo Asuquo

Role: primary

+234(0)7064559257

Anietie Ekwere

Role: backup

+234(7)089721411

Christiana F Ekpeyong

Role: primary

+234(0)8067685745

Okon Asuquo

Role: backup

+234(0)7063384541

Eneawan Edem

Role: primary

+234(0)8028457047

Victoria Usen

Role: backup

+234(0)7030227955

References

Explore related publications, articles, or registry entries linked to this study.

Seetharaman N, Chacko TV, Shankar SLR, Matthew AC. Measuring malnutrition - the roles of Z scores and the composite index of anthropometric failure. Indian Journal of Community Medicine. 2007; 32 (1): 35-39.

Reference Type BACKGROUND

Vijay DW, Bhawesh RD. Ready to use therapeutic food (RUTF): An overview.. Advances in life Sciences and Health. 2015; 2 (1): 1-15.

Reference Type BACKGROUND

Choudhury N, Ahmed T, Hossain MI, Islam MM, Sarker SA, Zeilani M, Clemens JD. Ready-to-Use Therapeutic Food Made From Locally Available Food Ingredients Is Well Accepted by Children Having Severe Acute Malnutrition in Bangladesh. Food Nutr Bull. 2018 Mar;39(1):116-126. doi: 10.1177/0379572117743929. Epub 2017 Dec 19.

Reference Type BACKGROUND
PMID: 29258336 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UUTH/AD/S/96/VOL.XXI/341

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.